FDA Inspection 991765 — Synovis Life Technologies, Inc. (sub. of Baxter Int'l, Inc.)

Synovis Life Technologies, Inc. (sub. of Baxter Int'l, Inc.) — FEI 2183620

The FDA completed an inspection of Synovis Life Technologies, Inc. (sub. of Baxter Int'l, Inc.) on October 18, 2016 in Saint Paul, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 18, 2016
Fiscal Year
2017
Product Type
Devices
Project Area
Compliance: Devices
Location
Saint Paul, MN (United States)

Citations

IDCFRDescription
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
310421 CFR 820.30(j)Design history file
317221 CFR 820.198(c)Investigation of device failures